Polyadenylic acid-containing cytoplasmic RNA increases in adenosine 3',5'-cyclic monophosphate-induced 'differentiated' neuroblastoma cells in culture.
D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone / Q000494:pharmacology; D001769:Blood; D002087:Butyrates / Q000494:pharmacology; D002454:Cell Differentiation; D002460:Cell Line; D002467:Cell Nucleus / Q000378:metabolism; D003470:Culture Media; D000242:Cyclic AMP / Q000494:pharmacology*; D003593:Cytoplasm / Q000378:metabolism*; D004247:DNA / Q000378:metabolism; D003609:Dactinomycin / Q000378:metabolism; D009474:Neurons; D011061:Poly A; D011458:Prostaglandins E / Q000494:pharmacology; D012333:RNA, Messenger / Q000096:biosynthesis* / Q000528:radiation effects; D011830:Radiation Effects; D012260:Ribonucleases / Q000494:pharmacology; D014965:X-Rays
D002087:Butyrates; D003470:Culture Media; D011458:Prostaglandins E; D012333:RNA, Messenger; D003609:Dactinomycin; D011061:Poly A; D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; D004247:DNA; D000242:Cyclic AMP; D012260:Ribonucleases